Comerica Bank Alnylam Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 1,912 shares of ALNY stock, worth $451,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,912

Previous 12,588 84.81%

Holding current value

$451,136

Previous $3.06 Million 82.83%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $2.5 Million - $3.06 Million	-10,676 Reduced 84.81%	1,912 $525,000
Q2 2024 Aug 15, 2024	SELL	$143.31 - $247.0 $59,473 - $102,505	-415 Reduced 3.19%	12,588 $3.06 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $52,743 - $71,352	-360 Reduced 2.69%	13,003 $1.94 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $9,538 - $12,383	-63 Reduced 0.47%	13,363 $2.56 Million
Q3 2023 Nov 21, 2023	BUY	$170.77 - $211.65 $2.29 Million - $2.84 Million	13,426 New	13,426 $2.38 Million
Q4 2022 Jan 26, 2023	BUY	$185.53 - $241.31 $6,308 - $8,204	34 Added 0.29%	11,761 $0
Q3 2022 Oct 28, 2022	BUY	$138.54 - $232.0 $8,450 - $14,152	61 Added 0.52%	11,727 $2.3 Million
Q1 2022 Apr 27, 2022	SELL	$127.18 - $173.91 $1,144 - $1,565	-9 Reduced 0.08%	11,666 $1.9 Million
Q4 2021 Feb 18, 2022	SELL	$159.56 - $209.29 $319 - $418	-2 Reduced 0.02%	11,675 $1.98 Million
Q3 2021 Nov 22, 2021	SELL	$169.75 - $207.73 $560,854 - $686,339	-3,304 Reduced 22.05%	11,677 $2.2 Million
Q2 2021 Aug 26, 2021	SELL	$128.63 - $176.89 $25,211 - $34,670	-196 Reduced 1.29%	14,981 $2.54 Million
Q1 2021 Apr 28, 2021	SELL	$126.83 - $175.69 $51,873 - $71,857	-409 Reduced 2.62%	15,177 $2.14 Million
Q4 2020 Jan 28, 2021	SELL	$122.97 - $147.0 $42,424 - $50,715	-345 Reduced 2.17%	15,586 $2.03 Million
Q3 2020 Oct 30, 2020	SELL	$121.19 - $165.49 $13,330 - $18,203	-110 Reduced 0.69%	15,931 $2.32 Million
Q2 2020 Jul 31, 2020	SELL	$104.21 - $156.44 $494,580 - $742,464	-4,746 Reduced 22.83%	16,041 $2.38 Million
Q1 2020 May 01, 2020	SELL	$93.12 - $133.99 $347,616 - $500,184	-3,733 Reduced 15.22%	20,787 $2.26 Million
Q4 2019 Feb 07, 2020	SELL	$74.51 - $124.23 $96,564 - $161,002	-1,296 Reduced 5.02%	24,520 $2.82 Million
Q3 2019 Oct 31, 2019	SELL	$70.9 - $87.82 $400,088 - $495,568	-5,643 Reduced 17.94%	25,816 $2.08 Million
Q2 2019 Aug 02, 2019	BUY	$65.86 - $92.79 $273,714 - $385,635	4,156 Added 15.22%	31,459 $0
Q1 2019 May 02, 2019	BUY	$72.76 - $93.45 $119,035 - $152,884	1,636 Added 6.37%	27,303 $0
Q4 2018 Feb 06, 2019	BUY	$62.67 - $88.33 $224,295 - $316,133	3,579 Added 16.2%	25,667 $2.03 Million
Q3 2018 Nov 01, 2018	BUY	$87.52 - $122.67 $521,269 - $730,622	5,956 Added 36.92%	22,088 $1.69 Million
Q2 2018 Aug 01, 2018	BUY	$88.31 - $107.8 $1,942 - $2,371	22 Added 0.14%	16,132 $1.65 Million
Q1 2018 May 01, 2018	SELL	$115.92 - $148.54 $5,448 - $6,981	-47 Reduced 0.29%	16,110 $1.55 Million
Q4 2017 Feb 02, 2018	BUY	$114.49 - $139.98 $31,141 - $38,074	272 Added 1.71%	16,157 $2.16 Million
Q3 2017 Nov 06, 2017	BUY	$72.53 - $118.27 $1.15 Million - $1.88 Million	15,885	15,885 $1.95 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account